Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Rich Pharmaceuticals Inc RCHA

Healthcare Biotechnology
Rich Pharmaceuticals Inc is a United States based development stage biopharmaceutical company. It is focused on the development on RP-323 for the treatment of Hodgkin's lymphoma (HL), Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells in the patients depleted of these elements due to various conditions. RP-323 is a naturally occurring compound that has properties... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:RCHA)

Geopulse Exploration (dba Cannco Brands and Development) Delivers Corporate Update

GlobeNewswire November 25, 2019

Rich Pharmaceuticals Reaches Agreement with Geopulse Exploration, Inc. (Cannco Brands)

GlobeNewswire October 7, 2019

Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients

GlobeNewswire April 10, 2018

Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma

GlobeNewswire March 14, 2018

Rich Pharmaceuticals' Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy

GlobeNewswire March 6, 2018

UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials

GlobeNewswire December 5, 2017

Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials

GlobeNewswire December 5, 2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson's Disease

Marketwired July 18, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials

Marketwired June 21, 2017
View More News ››

Opinion & Analysis (OTCPK:RCHA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:RCHA)

re:HUGE VOLUME

Should be RCHA not RCHAE
reddeerman - March 21, 2017

HUGE VOLUME

Maybe worth checkiing out getting into the cannabis game. Large o/s tho
reddeerman - March 21, 2017

Next big thing?!

This thing is going to either explode in a few weeks or drop.... Worth the risk ? 
iMarketcheck13 - February 6, 2015
View more Bullboard ››

Quimbaya Gold Inc.

Quimbaya Gold Inc.

Quimbaya aims to consolidate gold reserves through exploration and acquisition of mining properties in Antioquia, Colombia ...
View More »